Ruben Mesa

52PUBLICATIONS
271CO-AUTHORS
Planning and decision makingRespiratory diseasesCell physiologyHaematological tumoursBasic pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jun 01, 2026
Expert Validation of an Artificial Intelligence-Enabled Trial Matching Solution Using Real-World Data From Patients With Cancer.

|Apr 10, 2026
Association Between Transfusion Status, Hemoglobin Levels, and Patient-Reported Outcomes in Myelofibrosis: A Post Hoc Clinical Trial Analysis.

Ruben Mesa, Jeanne M Palmer, Francesca Palandri

|Jun 27, 2025
Patient-Reported Outcomes and Provider Perceptions of Systemic Mastocytosis: Results From the PRISM Study.

Massimo Triggiani, Jessica Hobart, Iván Alvarez-Twose

|Jun 19, 2025
Time Without Transfusion Reliance (TWiTR): Integrating Survival Quality Into Myelofibrosis Treatment Strategies Based on the Phase 3 SIMPLIFY-1, SIMPLIFY-2, and MOMENTUM Trials.

Ruben A Mesa, Moshe Talpaz, Flora Mazerolle

|Mar 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT.

Nicola Polverelli, Juan Carlos Hernández-Boluda, Francesco Onida

|Mar 11, 2025
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial.

Raajit K Rampal, Sebastian Grosicki, Dominik Chraniuk

Pageof 9

Frequent Collaborators

7 joint publications

Srdan Verstovsek

7 joint publications

David A Tuveson

7 joint publications

Margaret Foti

7 joint publications

Vikas K Gupta